pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4708 |
Genomic Coordinates | chr14: 65335117 - 65335183 |
Description | Homo sapiens miR-4708 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4708-5p | ||||||||||||
Sequence | 9| AGAGAUGCCGCCUUGCUCCUU |29 | ||||||||||||
Evidence | Experimental | ||||||||||||
Experiments | Illumina | ||||||||||||
SNPs in miRNA |
|
||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | CCND1 | ||||||||||||||||||||
Synonyms | BCL1, D11S287E, PRAD1, U21B31 | ||||||||||||||||||||
Description | cyclin D1 | ||||||||||||||||||||
Transcript | NM_053056 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on CCND1 | |||||||||||||||||||||
3'UTR of CCND1 (miRNA target sites are highlighted) |
>CCND1|NM_053056|3'UTR 1 GGGCGCCAGGCAGGCGGGCGCCACCGCCACCCGCAGCGAGGGCGGAGCCGGCCCCAGGTGCTCCCCTGACAGTCCCTCCT 81 CTCCGGAGCATTTTGATACCAGAAGGGAAAGCTTCATTCTCCTTGTTGTTGGTTGTTTTTTCCTTTGCTCTTTCCCCCTT 161 CCATCTCTGACTTAAGCAAAAGAAAAAGATTACCCAAAAACTGTCTTTAAAAGAGAGAGAGAGAAAAAAAAAATAGTATT 241 TGCATAACCCTGAGCGGTGGGGGAGGAGGGTTGTGCTACAGATGATAGAGGATTTTATACCCCAATAATCAACTCGTTTT 321 TATATTAATGTACTTGTTTCTCTGTTGTAAGAATAGGCATTAACACAAAGGAGGCGTCTCGGGAGAGGATTAGGTTCCAT 401 CCTTTACGTGTTTAAAAAAAAGCATAAAAACATTTTAAAAACATAGAAAAATTCAGCAAACCATTTTTAAAGTAGAAGAG 481 GGTTTTAGGTAGAAAAACATATTCTTGTGCTTTTCCTGATAAAGCACAGCTGTAGTGGGGTTCTAGGCATCTCTGTACTT 561 TGCTTGCTCATATGCATGTAGTCACTTTATAAGTCATTGTATGTTATTATATTCCGTAGGTAGATGTGTAACCTCTTCAC 641 CTTATTCATGGCTGAAGTCACCTCTTGGTTACAGTAGCGTAGCGTGCCCGTGTGCATGTCCTTTGCGCCTGTGACCACCA 721 CCCCAACAAACCATCCAGTGACAAACCATCCAGTGGAGGTTTGTCGGGCACCAGCCAGCGTAGCAGGGTCGGGAAAGGCC 801 ACCTGTCCCACTCCTACGATACGCTACTATAAAGAGAAGACGAAATAGTGACATAATATATTCTATTTTTATACTCTTCC 881 TATTTTTGTAGTGACCTGTTTATGAGATGCTGGTTTTCTACCCAACGGCCCTGCAGCCAGCTCACGTCCAGGTTCAACCC 961 ACAGCTACTTGGTTTGTGTTCTTCTTCATATTCTAAAACCATTCCATTTCCAAGCACTTTCAGTCCAATAGGTGTAGGAA 1041 ATAGCGCTGTTTTTGTTGTGTGTGCAGGGAGGGCAGTTTTCTAATGGAATGGTTTGGGAATATCCATGTACTTGTTTGCA 1121 AGCAGGACTTTGAGGCAAGTGTGGGCCACTGTGGTGGCAGTGGAGGTGGGGTGTTTGGGAGGCTGCGTGCCAGTCAAGAA 1201 GAAAAAGGTTTGCATTCTCACATTGCCAGGATGATAAGTTCCTTTCCTTTTCTTTAAAGAAGTTGAAGTTTAGGAATCCT 1281 TTGGTGCCAACTGGTGTTTGAAAGTAGGGACCTCAGAGGTTTACCTAGAGAACAGGTGGTTTTTAAGGGTTATCTTAGAT 1361 GTTTCACACCGGAAGGTTTTTAAACACTAAAATATATAATTTATAGTTAAGGCTAAAAAGTATATTTATTGCAGAGGATG 1441 TTCATAAGGCCAGTATGATTTATAAATGCAATCTCCCCTTGATTTAAACACACAGATACACACACACACACACACACACA 1521 CAAACCTTCTGCCTTTGATGTTACAGATTTAATACAGTTTATTTTTAAAGATAGATCCTTTTATAGGTGAGAAAAAAACA 1601 ATCTGGAAGAAAAAAACCACACAAAGACATTGATTCAGCCTGTTTGGCGTTTCCCAGAGTCATCTGATTGGACAGGCATG 1681 GGTGCAAGGAAAATTAGGGTACTCAACCTAAGTTCGGTTCCGATGAATTCTTATCCCCTGCCCCTTCCTTTAAAAAACTT 1761 AGTGACAAAATAGACAATTTGCACATCTTGGCTATGTAATTCTTGTAATTTTTATTTAGGAAGTGTTGAAGGGAGGTGGC 1841 AAGAGTGTGGAGGCTGACGTGTGAGGGAGGACAGGCGGGAGGAGGTGTGAGGAGGAGGCTCCCGAGGGGAAGGGGCGGTG 1921 CCCACACCGGGGACAGGCCGCAGCTCCATTTTCTTATTGCGCTGCTACCGTTGACTTCCAGGCACGGTTTGGAAATATTC 2001 ACATCGCTTCTGTGTATCTCTTTCACATTGTTTGCTGCTATTGGAGGATCAGTTTTTTGTTTTACAATGTCATATACTGC 2081 CATGTACTAGTTTTAGTTTTCTCTTAGAACATTGTATTACAGATGCCTTTTTTGTAGTTTTTTTTTTTTTTATGTGATCA 2161 ATTTTGACTTAATGTGATTACTGCTCTATTCCAAAAAGGTTGCTGTTTCACAATACCTCATGCTTCACTTAGCCATGGTG 2241 GACCCAGCGGGCAGGTTCTGCCTGCTTTGGCGGGCAGACACGCGGGCGCGATCCCACACAGGCTGGCGGGGGCCGGCCCC 2321 GAGGCCGCGTGCGTGAGAACCGCGCCGGTGTCCCCAGAGACCAGGCTGTGTCCCTCTTCTCTTCCCTGCGCCTGTGATGC 2401 TGGGCACTTCATCTGATCGGGGGCGTAGCATCATAGTAGTTTTTACAGCTGTGTTATTCTTTGCGTGTAGCTATGGAAGT 2481 TGCATAATTATTATTATTATTATTATAACAAGTGTGTCTTACGTGCCACCACGGCGTTGTACCTGTAGGACTCTCATTCG 2561 GGATGATTGGAATAGCTTCTGGAATTTGTTCAAGTTTTGGGTATGTTTAATCTGTTATGTACTAGTGTTCTGTTTGTTAT 2641 TGTTTTGTTAATTACACCATAATGCTAATTTAAAGAGACTCCAAATCTCAATGAAGCCAGCTCACAGTGCTGTGTGCCCC 2721 GGTCACCTAGCAAGCTGCCGAACCAAAAGAATTTGCACCCCGCTGCGGGCCCACGTGGTTGGGGCCCTGCCCTGGCAGGG 2801 TCATCCTGTGCTCGGAGGCCATCTCGGGCACAGGCCCACCCCGCCCCACCCCTCCAGAACACGGCTCACGCTTACCTCAA 2881 CCATCCTGGCTGCGGCGTCTGTCTGAACCACGCGGGGGCCTTGAGGGACGCTTTGTCTGTCGTGATGGGGCAAGGGCACA 2961 AGTCCTGGATGTTGTGTGTATCGAGAGGCCAAAGGCTGGTGGCAAGTGCACGGGGCACAGCGGAGTCTGTCCTGTGACGC 3041 GCAAGTCTGAGGGTCTGGGCGGCGGGCGGCTGGGTCTGTGCATTTCTGGTTGCACCGCGGCGCTTCCCAGCACCAACATG 3121 TAACCGGCATGTTTCCAGCAGAAGACAAAAAGACAAACATGAAAGTCTAGAAATAAAACTGGTAAAACCCCAAAAAAAAA 3201 AAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 595.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714647. RNA binding protein: AGO2. Condition:mildMNase
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | Prostate Tissue |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRX1760583. RNA binding protein: AGO2. Condition:AGO-CLIP-LNCaP_A
... - Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al., 2016, Neoplasia (New York, N.Y.). |
Article |
- Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al. - Neoplasia (New York, N.Y.), 2016
MicroRNA (miRNA) deregulation in prostate cancer (PCa) contributes to PCa initiation and metastatic progression. To comprehensively define the cancer-associated changes in miRNA targeting and function in commonly studied models of PCa, we performed photoactivatable ribonucleoside-enhanced cross-linking immunoprecipitation of the Argonaute protein in a panel of PCa cell lines modeling different stages of PCa progression. Using this comprehensive catalogue of miRNA targets, we analyzed miRNA targeting on known drivers of PCa and examined tissue-specific and stage-specific pathway targeting by miRNAs. We found that androgen receptor is the most frequently targeted PCa oncogene and that miR-148a targets the largest number of known PCa drivers. Globally, tissue-specific and stage-specific changes in miRNA targeting are driven by homeostatic response to active oncogenic pathways. Our findings indicate that, even in advanced PCa, the miRNA pool adapts to regulate continuing alterations in the cancer genome to balance oncogenic molecular changes. These findings are important because they are the first to globally characterize miRNA changes in PCa and demonstrate how the miRNA target spectrum responds to staged tumorigenesis.
LinkOut: [PMID: 27292025]
|
CLIP-seq Support 1 for dataset GSM4903825 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / PID14_NS |
Location of target site | NM_053056 | 3UTR | AGUGGGGUUCUAGGCAUCUCUGUACUUUGCUUGCUCAUAUGC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161237 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903826 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / PID21_NS |
Location of target site | NM_053056 | 3UTR | AGUGGGGUUCUAGGCAUCUCUGUACUUUGCUUGCUCAUAUGC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161237 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_053056 | 3UTR | UUUAAAGUAGAAGAGGGUUUUAGGUAGAAAAACAUAUUCUUGUGCUUUUCCUGAUAAAGCACAGCUGUAGUGGGGUUCUAGGCAUCUCUGUACUUUGCUUGCUCAUAUGC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM4903834 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_b |
Location of target site | NM_053056 | 3UTR | UAUUCUUGUGCUUUUCCUGAUAAAGCACAGCUGUAGUGGGGUUCUAGGCAUCUCUGUACUUUGCUUGCUCAUAUGC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM4903835 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_c |
Location of target site | NM_053056 | 3UTR | UUUUUAAAGUAGAAGAGGGUUUUAGGUAGAAAAACAUAUUCUUGUGCUUUUCCUGAUAAAGCACAGCUGUAGUGGGGUUCUAGGCAUCUCUGUACUUUGCUUGCUCAUAUGC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset GSM4903836 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_a |
Location of target site | NM_053056 | 3UTR | UUUUCCUGAUAAAGCACAGCUGUAGUGGGGUUCUAGGCAUCUCUGUACUUUGCUUGCUCAUAUGC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 7 for dataset GSM4903837 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_b |
Location of target site | NM_053056 | 3UTR | AGAAAAACAUAUUCUUGUGCUUUUCCUGAUAAAGCACAGCUGUAGUGGGGUUCUAGGCAUCUCUGUACUUUGCUUGCUCAUAUGC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 8 for dataset GSM4903838 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_c |
Location of target site | NM_053056 | 3UTR | UGCUUUUCCUGAUAAAGCACAGCUGUAGUGGGGUUCUAGGCAUCUCUGUACUUUGCUUGCUCAUAUGC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 9 for dataset GSM714647 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / mildMNase, repB |
Location of target site | ENST00000227507.2 | 3UTR | UCUGUACUUUGCUUGCUCAUAUGCAUGUAGUCACUUUAUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
94 hsa-miR-4708-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT095681 | RBM27 | RNA binding motif protein 27 | 2 | 4 | ||||||||
MIRT104033 | USP42 | ubiquitin specific peptidase 42 | 2 | 6 | ||||||||
MIRT114773 | CMPK1 | cytidine/uridine monophosphate kinase 1 | 2 | 2 | ||||||||
MIRT246923 | CCND1 | cyclin D1 | 2 | 2 | ||||||||
MIRT392569 | ORAI2 | ORAI calcium release-activated calcium modulator 2 | 2 | 2 | ||||||||
MIRT443949 | LRIT3 | leucine rich repeat, Ig-like and transmembrane domains 3 | 2 | 2 | ||||||||
MIRT446695 | PAPPA | pappalysin 1 | 2 | 2 | ||||||||
MIRT447383 | VOPP1 | vesicular, overexpressed in cancer, prosurvival protein 1 | 2 | 2 | ||||||||
MIRT449321 | FAM120AOS | family with sequence similarity 120A opposite strand | 2 | 2 | ||||||||
MIRT449717 | C1orf61 | chromosome 1 open reading frame 61 | 2 | 2 | ||||||||
MIRT449738 | TAB2 | TGF-beta activated kinase 1/MAP3K7 binding protein 2 | 2 | 2 | ||||||||
MIRT450531 | PGLS | 6-phosphogluconolactonase | 2 | 2 | ||||||||
MIRT455650 | YARS | tyrosyl-tRNA synthetase | 2 | 2 | ||||||||
MIRT458036 | MRPL12 | mitochondrial ribosomal protein L12 | 2 | 2 | ||||||||
MIRT463468 | ZC3HAV1L | zinc finger CCCH-type containing, antiviral 1 like | 2 | 2 | ||||||||
MIRT466677 | TAF1D | TATA-box binding protein associated factor, RNA polymerase I subunit D | 2 | 4 | ||||||||
MIRT467789 | SLC2A14 | solute carrier family 2 member 14 | 2 | 2 | ||||||||
MIRT468167 | SGPL1 | sphingosine-1-phosphate lyase 1 | 2 | 2 | ||||||||
MIRT468652 | SECISBP2L | SECIS binding protein 2 like | 2 | 6 | ||||||||
MIRT469380 | RER1 | retention in endoplasmic reticulum sorting receptor 1 | 2 | 2 | ||||||||
MIRT470346 | PPP2R5E | protein phosphatase 2 regulatory subunit B'epsilon | 2 | 2 | ||||||||
MIRT472418 | NCKAP1 | NCK associated protein 1 | 2 | 2 | ||||||||
MIRT474612 | KLF3 | Kruppel like factor 3 | 2 | 2 | ||||||||
MIRT478703 | CSRNP2 | cysteine and serine rich nuclear protein 2 | 2 | 2 | ||||||||
MIRT481008 | BBC3 | BCL2 binding component 3 | 2 | 4 | ||||||||
MIRT483098 | TFPI | tissue factor pathway inhibitor | 2 | 2 | ||||||||
MIRT485113 | SHISA6 | shisa family member 6 | 2 | 2 | ||||||||
MIRT497533 | ZNF607 | zinc finger protein 607 | 2 | 2 | ||||||||
MIRT500644 | TUBB2A | tubulin beta 2A class IIa | 2 | 6 | ||||||||
MIRT500890 | STRN | striatin | 2 | 4 | ||||||||
MIRT501900 | MED13 | mediator complex subunit 13 | 2 | 2 | ||||||||
MIRT506646 | MAPK1 | mitogen-activated protein kinase 1 | 2 | 4 | ||||||||
MIRT512675 | ENO4 | enolase family member 4 | 2 | 2 | ||||||||
MIRT516977 | OR7D2 | olfactory receptor family 7 subfamily D member 2 | 2 | 2 | ||||||||
MIRT528754 | RPS27 | ribosomal protein S27 | 2 | 6 | ||||||||
MIRT539670 | ZBTB44 | zinc finger and BTB domain containing 44 | 2 | 2 | ||||||||
MIRT544129 | PPIL1 | peptidylprolyl isomerase like 1 | 2 | 2 | ||||||||
MIRT546382 | STOX2 | storkhead box 2 | 2 | 4 | ||||||||
MIRT562143 | IGFBP5 | insulin like growth factor binding protein 5 | 2 | 2 | ||||||||
MIRT568713 | TMEM30B | transmembrane protein 30B | 2 | 2 | ||||||||
MIRT571029 | CENPP | centromere protein P | 2 | 2 | ||||||||
MIRT572781 | ZNF277 | zinc finger protein 277 | 2 | 2 | ||||||||
MIRT573162 | SLC30A9 | solute carrier family 30 member 9 | 2 | 2 | ||||||||
MIRT609126 | NUDT3 | nudix hydrolase 3 | 2 | 2 | ||||||||
MIRT609284 | OAS3 | 2'-5'-oligoadenylate synthetase 3 | 2 | 2 | ||||||||
MIRT613430 | GALNT6 | polypeptide N-acetylgalactosaminyltransferase 6 | 2 | 2 | ||||||||
MIRT613770 | TTC38 | tetratricopeptide repeat domain 38 | 2 | 2 | ||||||||
MIRT616645 | LRAT | lecithin retinol acyltransferase | 2 | 4 | ||||||||
MIRT630892 | SLC25A33 | solute carrier family 25 member 33 | 2 | 2 | ||||||||
MIRT636526 | FAXC | failed axon connections homolog | 2 | 4 | ||||||||
MIRT641394 | NUBPL | nucleotide binding protein like | 2 | 2 | ||||||||
MIRT641412 | SCN2B | sodium voltage-gated channel beta subunit 2 | 2 | 2 | ||||||||
MIRT642528 | CERS4 | ceramide synthase 4 | 2 | 2 | ||||||||
MIRT643186 | HYPK | huntingtin interacting protein K | 2 | 2 | ||||||||
MIRT647800 | FRMD8 | FERM domain containing 8 | 2 | 2 | ||||||||
MIRT652150 | TRIM71 | tripartite motif containing 71 | 2 | 2 | ||||||||
MIRT652602 | TIMM8A | translocase of inner mitochondrial membrane 8A | 2 | 2 | ||||||||
MIRT661606 | C2orf15 | chromosome 2 open reading frame 15 | 2 | 2 | ||||||||
MIRT666339 | SKAP2 | src kinase associated phosphoprotein 2 | 2 | 2 | ||||||||
MIRT670414 | ELP2 | elongator acetyltransferase complex subunit 2 | 2 | 2 | ||||||||
MIRT671122 | ZNF573 | zinc finger protein 573 | 2 | 2 | ||||||||
MIRT671155 | ANKRD9 | ankyrin repeat domain 9 | 2 | 2 | ||||||||
MIRT671338 | FAM71F2 | family with sequence similarity 71 member F2 | 2 | 2 | ||||||||
MIRT671869 | ZNF429 | zinc finger protein 429 | 2 | 2 | ||||||||
MIRT671974 | IKZF3 | IKAROS family zinc finger 3 | 2 | 2 | ||||||||
MIRT672064 | KIAA0930 | KIAA0930 | 2 | 2 | ||||||||
MIRT672654 | SLC25A16 | solute carrier family 25 member 16 | 2 | 4 | ||||||||
MIRT672673 | GTF2H5 | general transcription factor IIH subunit 5 | 2 | 2 | ||||||||
MIRT672771 | UBE2V2 | ubiquitin conjugating enzyme E2 V2 | 2 | 2 | ||||||||
MIRT672929 | LRRC2 | leucine rich repeat containing 2 | 2 | 2 | ||||||||
MIRT673159 | C1orf50 | chromosome 1 open reading frame 50 | 2 | 2 | ||||||||
MIRT673272 | RUNDC1 | RUN domain containing 1 | 2 | 2 | ||||||||
MIRT673332 | THAP1 | THAP domain containing 1 | 2 | 2 | ||||||||
MIRT673351 | SLC35F6 | solute carrier family 35 member F6 | 2 | 2 | ||||||||
MIRT673667 | ZNF440 | zinc finger protein 440 | 2 | 2 | ||||||||
MIRT673904 | DCTN6 | dynactin subunit 6 | 2 | 2 | ||||||||
MIRT674096 | PLEKHA1 | pleckstrin homology domain containing A1 | 2 | 2 | ||||||||
MIRT674401 | MYCBP | MYC binding protein | 2 | 2 | ||||||||
MIRT674525 | PRR23A | proline rich 23A | 2 | 2 | ||||||||
MIRT674793 | NPR1 | natriuretic peptide receptor 1 | 2 | 2 | ||||||||
MIRT674833 | ADAMTS4 | ADAM metallopeptidase with thrombospondin type 1 motif 4 | 2 | 2 | ||||||||
MIRT675066 | FGD6 | FYVE, RhoGEF and PH domain containing 6 | 2 | 2 | ||||||||
MIRT675080 | CCR6 | C-C motif chemokine receptor 6 | 2 | 2 | ||||||||
MIRT675126 | FSD2 | fibronectin type III and SPRY domain containing 2 | 2 | 2 | ||||||||
MIRT679401 | IL10RB | interleukin 10 receptor subunit beta | 2 | 2 | ||||||||
MIRT689229 | RPS19 | ribosomal protein S19 | 2 | 2 | ||||||||
MIRT694008 | PPIL4 | peptidylprolyl isomerase like 4 | 2 | 2 | ||||||||
MIRT699671 | SFT2D2 | SFT2 domain containing 2 | 2 | 2 | ||||||||
MIRT706213 | ACOT9 | acyl-CoA thioesterase 9 | 2 | 2 | ||||||||
MIRT706548 | GJD2 | gap junction protein delta 2 | 2 | 2 | ||||||||
MIRT707418 | RRP7A | ribosomal RNA processing 7 homolog A | 2 | 2 | ||||||||
MIRT710648 | GLUL | glutamate-ammonia ligase | 2 | 2 | ||||||||
MIRT719393 | NPCA1 | Nasopharyngeal carcinoma 1 | 2 | 2 | ||||||||
MIRT720166 | PNPO | pyridoxamine 5'-phosphate oxidase | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|